HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)

HLB Therapeutics Revenue

HLB Therapeutics had revenue of 13.05B KRW in the quarter ending March 31, 2026, a decrease of -13.30%. This brings the company's revenue in the last twelve months to 67.56B, up 18.06% year-over-year. In the year 2025, HLB Therapeutics had annual revenue of 69.56B with 26.63% growth.

• Revenue (ttm): 67.56B
• Revenue Growth: +18.06%
• P/S Ratio: 3.43
• Revenue / Employee: 1.38B
• Employees: 49
• Market Cap: 231.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	69.56B	14.63B	26.63%
Dec 31, 2024	54.93B	2.34B	4.45%
Dec 31, 2023	52.59B	10.19B	24.03%
Dec 31, 2022	42.40B	-1.18B	-2.72%
Dec 31, 2021	43.59B	656.63M	1.53%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error